Items where authors include "Quirke, P."

Export as [feed] Atom [feed] RSS
Number of items: 19.

Article

Huber, A.R., Pleguezuelos-Manzano, C., Puschhof, J. et al. (14 more authors) (2024) Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell, 42 (3). 487-496.E6. ISSN 1535-6108

Hilgers, L., Ghaffari Laleh, N., West, N.P. orcid.org/0000-0002-0346-6709 et al. (13 more authors) (2024) Automated curation of large‐scale cancer histopathology image datasets using deep learning. Histopathology. ISSN 0309-0167

West, N. orcid.org/0000-0002-0346-6709, Jiang, X., Hoffmeister, M. et al. (16 more authors) (2024) End-to-end prognostication in colorectal cancer by Deep Learning: a multicentric retrospective study. The Lancet: Digital Health, 6 (1). E33-E43. ISSN 2589-7500

Caley, L.R. orcid.org/0000-0001-8957-1018, Wood, H.M. orcid.org/0000-0003-3009-5904, Bottomley, D. orcid.org/0009-0000-5749-2710 et al. (9 more authors) (2023) The gut microbiota in adults with cystic fibrosis compared to colorectal cancer. Journal of Cystic Fibrosis. ISSN 1569-1993

Hartwig, M.F.S. orcid.org/0000-0001-7102-6951, Bulut, M., Ravn-Eriksen, J. et al. (11 more authors) (2023) Combined endoscopic and laparoscopic surgery (CELS) for early colon cancer in high-risk patients. Surgical Endoscopy, 37 (11). pp. 8511-8521. ISSN 0930-2794

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Elliott, F. orcid.org/0000-0002-3239-6914, Sapanara, N. orcid.org/0009-0005-0994-837X et al. (51 more authors) (2023) Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer. Clinical Cancer Research, 29 (20). pp. 4153-4165. ISSN 1078-0432

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Elliott, F. orcid.org/0000-0002-3239-6914, Sapanara, N. orcid.org/0009-0005-0994-837X et al. (51 more authors) (2023) Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer. Clinical Cancer Research, 29 (20). pp. 4153-4165. ISSN 1078-0432

Wagner, S.J., Reisenbüchler, D., West, N.P. et al. (46 more authors) (2023) Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study. Cancer Cell, 41. ISSN 1535-6108

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Elliott, F. et al. (24 more authors) (2021) Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer. Clinical Cancer Research, 27 (12). pp. 3422-3431. ISSN 1078-0432

Coggins, R.P., Cawkwell, L., Bell, S.M. et al. (4 more authors) (2005) Association between family history and mismatch repair in colorectal cancer. Gut, 54. pp. 636-642. ISSN 0017-5749

Pennica, D., Swanson, T.A., Welsh, J.W. et al. (17 more authors) (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proceedings of the National Academy of Sciences, 95 (25). pp. 14717-14722. ISSN 0027-8424

Proceedings Paper

Williams, C.J.M., Elliott, F., Shires, M. et al. (58 more authors) (2023) Association between artificial intelligence- (AI) assisted tumour AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): an observational cohort study. In: The Journal of Pathology. 5th Joint Meeting with the Royal Society of Medicine, 214th Scientific Meeting of the Pathological Society of Great Britain & Ireland, 23 Jan - 02 Feb 2023, London, UK. Wiley , S16-S16.

Cartlidge, C., Richman, S. orcid.org/0000-0003-3993-5041, Hemmings, G. et al. (5 more authors) (2023) Artificial Intelligence (AI)-Assisted HER2 Immunohistochemistry (IHC) Membranous Scoring in Stage IV Colorectal Cancer (CRC) Tissue Microarrays (TMAs). In: The Journal of Pathology. 14th Joint Meeting of the BDIAP and The Pathological Society, 27-29 Jun 2023, Liverpool, UK. Wiley , S15.

Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.

Williams, C. orcid.org/0000-0002-1574-653X, Gray, R.G., Shires, M. et al. (17 more authors) (2023) Artificial intelligence-assisted evaluation of tumor infiltrating CD3+ and CD8+ T cells for prognostication and prediction of benefit from adjuvant chemotherapy in early stage colorectal cancer (CRC): A retrospective analysis of the QUASAR trial. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 204.

Williams, C. orcid.org/0000-0002-1574-653X, Elliott, F., Shires, M. et al. (17 more authors) (2023) Association between artificial intelligence (AI) -assisted tumor AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): An observational cohort study. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 203.

Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.

Marks, K.M., Hall, H., Wu, X. et al. (3 more authors) Exposure to enterotoxigenic bacteroides fragilis (ETBF) bacteria found in association with colorectal cancer increases clonal mutations in mice. In: The Journal of Pathology. Winter Meeting: Unleashing the edge power of pathology, 31 Jan - 02 Feb 2023, London, UK. , S7-S7.

This list was generated on Sun Apr 14 13:31:05 2024 BST.